首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1588575

全球酵素連結免疫吸附檢測市場 - 2024-2031

Global Enzyme-Linked Immunosorbent Assay Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球酵素連結免疫吸附檢測市場規模達21.4億美元，預計2031年將達到33.5億美元，2024-2031年預測期間複合年成長率為5.8%。

酵素連結免疫吸附測定可用於檢測和估計荷爾蒙水平，如人類絨毛膜促性腺激素 (HCG)、卵泡刺激素 (FSH) 和睪固酮，以及追蹤社區中的疾病爆發，如衣原體或流感（流感），並篩檢捐血中可能的病毒成分，例如愛滋病毒。它可以檢測非醫療藥物的使用情況，例如體內是否有安非他明和可卡因。

由於酶聯免疫吸附測定檢測抗體的特異性和識別性，全球範圍內不斷增加的傳染病預計將推動對酶聯免疫吸附測定檢測的需求。例如，根據世界衛生組織 (WHO) 2024 年全球肝炎報告，病毒性肝炎導致的死亡人數正在上升。該疾病是世界第二大傳染病死亡原因，每年造成 130 萬人死亡。

市場動態：

驅動程式和限制

傳染病發生率增加

傳染病發病率的上升預計將推動酶聯免疫吸附測定市場的成長。隨著傳染病數量的不斷增加，實驗室對酵素連結免疫吸附測定測試的需求不斷增加。使用 ELISA 可以檢測和測量針對萊姆病、布魯氏菌病、梅毒、HIV 和肝炎等多種傳染病的抗體。

酵素連結免疫吸附測定是最廣泛使用的診斷程序之一，用於識別與傳染病相關的抗體、抗原和其他生物標記。隨著傳染病數量的不斷增加，政府組織、診斷中心和其他實驗室依靠酵素連結免疫吸附測定來檢測抗體。全球範圍內的傳染病數量不斷增加。

例如，2022 年，疾病預防控制中心從州衛生機構和哥倫比亞特區收到約 63,000 例萊姆病病例的報告。這一數字反映了常規國家監測期間記錄的病例，這只是公共衛生專業人員追蹤疾病的一種方法。根據最近使用替代方法的預測，美國每年將有大約 476,000 人被診斷出患有萊姆病並接受治療。這個數字可能包括根據臨床懷疑接受治療但沒有萊姆病的患者。

這些傳染病以及其他疾病需要利用酵素連結免疫吸附測定試劑盒來檢測抗體和生物標記。因此，傳染病發病率的增加預計將推動酶聯免疫吸附測定市場的成長。

替代技術的替代威脅

其他技術替代的機會是 ELISA（酶聯免疫吸附測定）市場成長和採用的主要障礙。隨著創新診斷和研究技術的出現，它們帶來了諸如更高的靈敏度、更快的發現和更低的成本等優勢，有可能取代或減少傳統 ELISA 檢測的必要性。因此，上述因素可能會阻礙酵素連結免疫吸附檢測市場的發展

Enzyme-linked Immunosorbent Assay is useful for detecting and estimating hormone levels such as human chorionic gonadotropin (HCG), follicle-stimulating hormone (FSH), and testosterone, as well as tracking disease outbreaks in communities such as chlamydia or influenza (the flu), and screening blood donations for possible viral components such as HIV. It detects nonmedical drug usage, such as the presence of amphetamines and cocaine in the body.

Rising infectious diseases globally are expected to drive the demand for enzyme-linked immunosorbent assay tests due to their specificity and identification of the antibodies. For instance, according to the World Health Organization's (WHO) 2024 Global Hepatitis Report, the number of deaths from viral hepatitis is rising. The disease is the second leading infectious cause of death in the world, accounting for 1.3 million deaths annually.

Market Dynamics: Drivers & Restraints

Increasing incidence of infectious diseases

The rising incidence of infectious diseases is expected to drive the enzyme-linked immunosorbent assay market growth. With the rising number of infectious diseases, there is a growing demand for enzyme-linked immunosorbent assay tests in laboratories. Antibodies against several infectious diseases such as Lyme disease, brucellosis, syphilis HIV and hepatitis among others can be detected and measured using ELISA.

Enzyme-linked immunosorbent assay is one of the most widely used diagnostic procedures for identifying antibodies, antigens, and other biomarkers linked to infectious illnesses. With the rising number of infectious diseases, government organizations, diagnostic centers and other laboratories depend on enzyme-linked immunosorbent assay for detecting the antibodies. There is a growing number of infectious diseases globally.

For instance, in 2022, the CDC received reports of about 63,000 cases of Lyme disease from state health agencies and the District of Columbia. This figure reflects cases recorded during routine national surveillance, which is simply one method used by public health professionals to track diseases. According to recent predictions utilizing alternative approaches, approximately 476,000 people in the United States will be identified and treated for Lyme disease each year. This number is likely to include patients treated based on clinical suspicion but do not have Lyme disease.

These infectious diseases, along with other diseases, require the utilization of enzyme-linked immunosorbent assay kits to detect antibodies and biomarkers. Thus, the increasing incidence of infectious diseases is expected to drive the Enzyme-Linked Immunosorbent Assay market growth.

Threat of substitution from alternative technologies

The chance of substitution from other technologies is a key obstacle to the growth and adoption of the ELISA (Enzyme-Linked Immunosorbent Assay) market. As innovative diagnostic and research technologies emerge, they provide benefits such as increased sensitivity, faster findings, and lower costs, potentially replacing or reducing the necessity for traditional ELISA assays. Thus, the above factors could hinder the enzyme-linked immunosorbent assay market

Segment Analysis

The global enzyme-linked immunosorbent assay market is segmented based on test type, product, application, end-user and region.

Sandwich ELISA segment is expected to dominate the enzyme-linked immunosorbent assay market share

The sandwich ELISA segment is expected to hold a major portion of the enzyme-linked immunosorbent assay market share. Sandwich ELISAs are the most common type of ELISA. The antigen is sandwiched between two specific antibodies, often known as matched antibody pairs. A microplate is covered with a capture antibody, a sample is added, and the protein of interest adheres to the plate and becomes immobilized.

A sandwich ELISA is more sensitive and robust because the antibody binds to two different sites on the antigen. This improves the binding selectivity of both the primary capture and detection antibodies to the antigen. The sandwich ELISA format is widely utilized due to its sensitivity and specificity.

New sandwich ELISA kits are being introduced into the market by several players which could contribute to the segment's expansion. An increasing number of product launches could help drive the segment's growth. For instance, in June 2024, ArcticZymes Technologies launched its SAN HQ 2.0 ELISA kit. This traditional sandwich ELISA is designed to detect and quantify the SAN HQ 2.0 enzyme in samples taken from the manufacturing stages of a complicated biomanufacturing process, such as the creation of viral vectors.

Thus, the sandwich ELISA segment is expected to hold the major portion of the enzyme-linked immunosorbent assay market share with the increasing innovation of new sandwich ELISA kits and their effectiveness in finding antibodies over other types of tests.

Geographical Analysis

North America is expected to hold a significant position in the enzyme-linked immunosorbent assay market share

North America is expected to hold a dominant position in the enzyme-linked immunosorbent assay market share owing to the increasing innovation of technological products, increasing research and development, the presence of a large number of key market players, and the rising incidence of infectious diseases. The region has highly equipped laboratories and it will invest more in the R&D department.

Several key players introduce a wide range of enzyme-linked immunosorbent assay products and kits with advanced features which could expand the region's market expansion. For instance, on February 13, 2023, Charles River Laboratories International, Inc. launched its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics.

Similarly, on May 24, 2022, Molecular Devices, LLC. unveiled five ready-made workcells for enzyme-linked immunosorbent assay (ELISA) workflows, with automation capabilities ranging from entry-level to advanced. Automation of labor-intensive plate-based assays improves walkaway time, throughput, and reproducibility by lowering the number of common, repetitive, hands-on steps for researchers.

The introduction of advanced instruments and systems will increase the adoption of these enzyme-linked immunosorbent assay products by several laboratories, diagnostic centers and research institutes, which will increase the demand for the products and expand of region's market as well. Several market players in the region invest huge resources in innovating enzyme-linked immunosorbent assay products. Thus, the above factors are expected to drive the region's market growth.

Market Segmentation

By Test Type

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

By Product

Kits & Reagents
ELISA Analyzers
- Automated
- Semi-automated

By Application

Drug Discovery
Infectious Diseases
Cancer Detection
Protein Quantification
Others

By End-user

Hospitals
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, Inc., American Laboratory Products Company (ALPCO), ZEUS Scientific, Inc., Life Technologies Corporation, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, Biomerieux S.A., Gemelli Biotech, BD

and Enzo Biochem Inc. among others.

Why Purchase the Report?

To visualize the global enzyme-linked immunosorbent assay market segmentation based on test type, product, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of enzyme-linked immunosorbent assay market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global enzyme-linked immunosorbent assay market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by Product
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing incidence of infectious diseases
- 4.1.2. Restraints
  - 4.1.2.1. Threat of substitution from alternative technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Test Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 6.1.2. Market Attractiveness Index, By Test Type
6.2. Direct ELISA*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Indirect ELISA
6.4. Sandwich ELISA
6.5. Competitive ELISA

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Kits & Reagents*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. ELISA Analyzers
- 7.3.1. Automated
- 7.3.2. Semi-automated

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Infectious Diseases
8.4. Cancer Detection
8.5. Protein Quantification
8.6. Others

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic and Research Institutes
9.4. Pharmaceutical & Biotechnology Companies
9.5. Diagnostic Laboratories
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
  - 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.3.1. The U.S.
  - 10.2.3.2. Canada
  - 10.2.3.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
  - 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.3.1. Germany
  - 10.3.3.2. UK
  - 10.3.3.3. France
  - 10.3.3.4. Italy
  - 10.3.3.5. Spain
  - 10.3.3.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
  - 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.4.1. Brazil
  - 10.4.4.2. Argentina
  - 10.4.4.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
  - 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.4.1. China
  - 10.5.4.2. India
  - 10.5.4.3. Japan
  - 10.5.4.4. South Korea
  - 10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. American Laboratory Products Company (ALPCO)
12.3. ZEUS Scientific, Inc.
12.4. Life Technologies Corporation
12.5. Bio-Rad Laboratories, Inc.
12.6. QuidelOrtho Corporation
12.7. bioMerieux S.A.
12.8. Gemelli Biotech
12.9. BD
12.10. Enzo Biochem Inc.

LIST NOT EXHAUSTIVE